当前位置:首页 - 行情中心 - 沃森生物(300142) - 财务分析 - 现金流量表

沃森生物

(300142)

  

流通市值:178.45亿  总市值:180.89亿
流通股本:15.78亿   总股本:15.99亿

现金流量表

报告期2026-09-302026-06-302026-03-312025-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金1,738,610,725.891,127,515,644.26441,691,381.882,608,820,008.55
  收到的税费返还10,734.49--6,958,581.51
  收到其他与经营活动有关的现金86,910,283.6852,004,986.7827,216,907.66173,137,841.91
  经营活动现金流入小计1,825,531,744.061,179,520,631.04468,908,289.542,788,916,431.97
  购买商品、接受劳务支付的现金924,803,792.11638,552,340.55302,965,750.731,719,060,891.19
  支付给职工以及为职工支付的现金299,503,503.75213,563,711.65124,192,531.74351,293,078.4
  支付的各项税费146,683,850.9989,022,419.0734,284,138.45138,407,899.77
  支付其他与经营活动有关的现金101,427,071.6364,464,872.7827,704,921.6689,228,396.45
  经营活动现金流出小计1,472,418,218.481,005,603,344.05489,147,342.582,297,990,265.81
  经营活动产生的现金流量净额353,113,525.58173,917,286.99-20,239,053.04490,926,166.16
二、投资活动产生的现金流量:
  收回投资收到的现金10,297,692.0810,297,692.086,661,283.13188,751,283.69
  取得投资收益收到的现金3,131,258.13--3,444,383.94
  处置固定资产、无形资产和其他长期资产收回的现金净额50,349.8350,349.83-699,903.18
  收到的其他与投资活动有关的现金300,000,000311,401,207.19--
  投资活动现金流入小计313,479,300.04321,749,249.16,661,283.13192,895,570.81
  购建固定资产、无形资产和其他长期资产支付的现金223,875,296.61161,691,440.2994,889,103.18509,544,939.65
  投资支付的现金269,100,000193,500,00050,000,000-
  支付其他与投资活动有关的现金-11,401,207.19--
  投资活动现金流出小计492,975,296.61366,592,647.48144,889,103.18509,544,939.65
  投资活动产生的现金流量净额-179,495,996.57-44,843,398.38-138,227,820.05-316,649,368.84
三、筹资活动产生的现金流量:
  吸收投资收到的现金3,550,000--2,702,500
  其中:子公司吸收少数股东投资收到的现金3,550,000--2,702,500
  取得借款收到的现金1,168,829,455.021,122,404,834.83952,570,000159,000,000
  收到其他与筹资活动有关的现金144,046,436.2574,690,053.1324,690,053.13144,098,105.75
  筹资活动现金流入小计1,316,425,891.271,197,094,887.96977,260,053.13305,800,605.75
  偿还债务支付的现金120,296,654.4120,296,654.4-393,694,507.64
  分配股利、利润或偿付利息支付的现金273,346,963.43263,923,824.4354,459,702.96789,862,333.69
  其中:子公司支付给少数股东的股利、利润---760,868,500
  支付其他与筹资活动有关的现金1,535,622,060.861,524,003,567.471,145,806,224.041,706,427,438.87
  筹资活动现金流出小计1,929,265,678.691,908,224,046.31,200,265,9272,889,984,280.2
  筹资活动产生的现金流量净额-612,839,787.42-711,129,158.34-223,005,873.87-2,584,183,674.45
四、汇率变动对现金及现金等价物的影响-6,625,811.38-3,215,886.35-1,147,114.85-951,793.34
五、现金及现金等价物净增加额-445,848,069.79-585,271,156.08-382,619,861.81-2,410,858,670.47
  加:期初现金及现金等价物余额1,348,244,145.541,348,244,145.541,348,244,145.543,759,102,816.01
  期末现金及现金等价物余额902,396,075.75762,972,989.46965,624,283.731,348,244,145.54
补充资料:
  净利润-45,939,173.56-125,157,091.43
  资产减值准备--68,218,942.13-251,664,603.63
  固定资产和投资性房地产折旧-114,632,252.43-261,911,123.09
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-114,632,252.43-261,911,123.09
  无形资产摊销-53,115,418.33-119,364,342.7
  长期待摊费用摊销-8,719,602.36-19,665,557.34
  处置固定资产、无形资产和其他长期资产的损失--351,321.33--81,071.48
  固定资产报废损失-232,701.44-1,011,398.04
  公允价值变动损失-58,734,900--29,676,000
  财务费用-8,308,429.96--20,919,436.84
  投资损失-429,568.1--2,554,430.79
  递延所得税-552,953.22--15,513,603.88
  其中:递延所得税资产减少-3,688,704.69--6,253,912.1
    递延所得税负债增加--3,135,751.47--9,259,691.78
  存货的减少--39,181,867.61-162,932,645.67
  经营性应收项目的减少-137,748,365.67-111,912,551.74
  经营性应付项目的增加--151,055,376.77--504,759,687.96
  现金的期末余额-762,972,989.46-1,348,244,145.54
  减:现金的期初余额-1,348,244,145.54-3,759,102,816.01
  现金及现金等价物的净增加额--585,271,156.08--2,410,858,670.47
公告日期2026-10-302026-08-292026-04-282026-03-28
审计意见(境内)标准无保留意见
TOP↑